Primemd Inc.
PRMD
$0.00
$0.000.00%
OTC PK
| 12/31/2008 | 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | |
|---|---|---|---|---|---|
| Revenue | 16.67% | 78.22% | 53.02% | 37.80% | 11.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.67% | 78.22% | 53.02% | 37.80% | 11.94% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 16.67% | 78.22% | 53.02% | 37.80% | 11.94% |
| SG&A Expenses | -56.75% | -48.39% | -37.86% | -34.44% | 17.48% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | -20.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -55.97% | -47.74% | -37.32% | -33.97% | 16.69% |
| Operating Income | 78.83% | 76.81% | 58.97% | 50.23% | -18.33% |
| Income Before Tax | -135.33% | -137.30% | -149.29% | -151.93% | 240.15% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -135.33% | -137.30% | -149.29% | -151.93% | 240.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -135.33% | -137.30% | -149.29% | -151.93% | 240.15% |
| EBIT | 78.83% | 76.81% | 58.97% | 50.23% | -18.33% |
| EBITDA | 80.34% | 78.17% | 59.99% | 51.18% | -19.37% |
| EPS Basic | -135.41% | -137.34% | -149.25% | -151.89% | 240.15% |
| Normalized Basic EPS | -142.71% | -145.04% | -158.81% | -172.22% | 216.37% |
| EPS Diluted | -135.41% | -137.34% | -149.25% | -151.89% | 240.15% |
| Normalized Diluted EPS | -142.71% | -145.04% | -158.81% | -172.22% | 216.37% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |